Clinical Validation of Targeted and Untargeted Metabolomics Testing for Genetic Disorders: A 3 Year Comparative Study
Naif A. M. Almontashiri(Taibah University), Roy W A Peake(Boston Children's Hospital), Mark D. Kellogg(Brigham and Women's Hospital), Li Zha(Xuzhou Medical College), Olaf A. Bodamer(Broad Institute), Terence Law(Boston University)
Cited by 38
Related Papers
Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
|Nature|2000|1.7k
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Sweetened Beverage Consumption, Incident Coronary Heart Disease, and Biomarkers of Risk in Men
|Circulation|2012|509
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326